Tenyoukai Central Clinic

Kagoshima 892-0822

1 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation, Elevated Lp(a), Prevention of Stroke or Systemic Embolism

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early